Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Total 13F shares
-
860,090
-
Share change
-
+814,919
-
Total reported value
-
$1,083,000
-
Price per share
-
$1.26
-
Number of holders
-
12
-
Value change
-
+$1,026,020
-
Number of buys
-
9
Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q2 2016
As of 30 Jun 2016,
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
860,090 shares.
The largest 10 holders included
Sio Capital Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, A.R.T. Advisors, LLC, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, WELLS FARGO & COMPANY/MN, UBS Group AG, Acrospire Investment Management LLC, and MANUFACTURERS LIFE INSURANCE COMPANY, THE.
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.